Ongoing research and innovation are critical for improving cancer outcomes. Advances in genomics, targeted therapies, and biomarker research are leading to more effective and less toxic treatments. Clinical trials offer patients access to cutting-edge therapies and contribute to the overall knowledge base, helping to refine current treatment guidelines and develop new strategies for combating cancer.